Evidence map›Paper›PMID 35728458›Full record

ArticleDiagnostic microbiology and infectious disease2022

User acceptability of saliva and gargle samples for identifying COVID-19 positive high-risk workers and household contacts.

Kirsty McLennan, Ellen Barton, Christie Lang, Ian R Adams, Gina McAllister, Martin A M Reijns, Kate Templeton, Ingólfur Johannessen, Alastair Leckie, Nick Gilbert

Open access · hybridAbstract read
In one paragraph

Article in Diagnostic microbiology and infectious disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Diagnostic performance, stability, and acceptability of self-collected saliva without additives for SARS-CoV-2 molecular diagnosis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kirsty McLennanOccupational Health and Safety Service, Astley Ainsley Hospital, NHS Lothian, Edinburgh, UK. Electronic address: Kirsty.Mclennan2@nhs.scot.
Ellen BartonOccupational Health and Safety Service, Astley Ainsley Hospital, NHS Lothian, Edinburgh, UK.
Christie LangOccupational Health and Safety Service, Astley Ainsley Hospital, NHS Lothian, Edinburgh, UK.
Ian R AdamsMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, UK.
Gina McAllisterClinical Microbiology and Virology, Directorate of Laboratory Medicine, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.
Martin A M ReijnsMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, UK.
Kate TempletonClinical Microbiology and Virology, Directorate of Laboratory Medicine, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.
Ingólfur JohannessenClinical Microbiology and Virology, Directorate of Laboratory Medicine, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.
Alastair LeckieOccupational Health and Safety Service, Astley Ainsley Hospital, NHS Lothian, Edinburgh, UK.
Nick GilbertMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, UK. Electronic address: nick.gilbert@ed.ac.uk.
NHS Lothian · GBInstitute of Genetics and Cancer · GB

Funding

Medical Research Council MC_UU_00007/13Medical Research Council MC_UU_00007/6
6 · The paper itself

Abstract

Throughout the COVID-19 pandemic nasopharyngeal or nose and/or throat swabs (NTS) have been the primary approach for collecting patient samples for the subsequent detection of viral RNA. However, this procedure, if undertaken correctly, can be unpleasant and therefore deters individuals from providing high quality samples. To overcome these limitations other modes of sample collection have been explored. In a cohort of frontline health care workers we have compared saliva and gargle samples to gold-standard NTS. 93% of individuals preferred providing saliva or gargle samples, with little sex-dependent variation. Viral titers collected in samples were analyzed using standard methods and showed that gargle and saliva were similarly comparable for identifying COVID-19 positive individuals compared to NTS (92% sensitivity; 98% specificity). We suggest that gargle and saliva collection are viable alternatives to NTS swabs and may encourage testing to provide better disease diagnosis and population surveillance.

Indexed as

COVID-19COVID-19 TestingHumansMouthwashesNasopharynxPandemicsRNA, ViralSalivaSARS-CoV-2Specimen HandlingMouthwashesRNA, ViralCOVID-19DiagnosticsHealth Care WorkersSalivaStorage Conditions

Identifiers

PMID35728458
PMCPMC9132684
OpenAlexW4281553144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.